MariMed Inc.
MRMD
$0.09
$0.001.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.42% | -2.05% | 0.06% | 0.26% | 4.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.42% | -2.05% | 0.06% | 0.26% | 4.63% |
| Cost of Revenue | 2.47% | 0.21% | 6.32% | 21.83% | 8.43% |
| Gross Profit | -2.50% | -5.19% | -8.10% | -26.61% | -0.33% |
| SG&A Expenses | -2.97% | -5.45% | 10.51% | -5.99% | 11.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.36% | -2.05% | 8.00% | 10.49% | 9.59% |
| Operating Income | 1.63% | -1.99% | -135.11% | -151.20% | -48.38% |
| Income Before Tax | 45.67% | 25.10% | -750.50% | 66.22% | -273.58% |
| Income Tax Expenses | 321.22% | -20.21% | 67.51% | 872.10% | -85.32% |
| Earnings from Continuing Operations | -197.07% | 22.51% | -319.50% | 19.11% | 76.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 56.25% | 108.33% | -433.33% | 90.00% | -260.00% |
| Net Income | -193.04% | 23.14% | -320.03% | 19.32% | 76.38% |
| EBIT | 1.63% | -1.99% | -135.11% | -151.20% | -48.38% |
| EBITDA | 3.00% | 5.82% | -54.34% | -64.40% | -23.58% |
| EPS Basic | -188.46% | 25.00% | -308.57% | 20.37% | 77.19% |
| Normalized Basic EPS | -- | 0.00% | -510.00% | -1,700.00% | -100.00% |
| EPS Diluted | -284.62% | 25.00% | -308.57% | 20.37% | 77.19% |
| Normalized Diluted EPS | -- | 0.00% | -510.00% | -1,700.00% | -100.00% |
| Average Basic Shares Outstanding | 3.16% | 2.74% | 1.96% | 1.39% | 2.02% |
| Average Diluted Shares Outstanding | 3.16% | 2.74% | 1.96% | 1.39% | 2.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |